Cargando…

Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages

Oncolytic viruses (OVs) for cancer treatment are in a rapid stage of development, and the direct tumor lysis and activation of a comprehensive host immune response are irreplaceable advantages of cancer immunotherapy. However, excessive antiviral immune responses also restrict the spread of OVs in v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Zhen, Liu, Xiyu, Fan, Guixiang, Na, Jintong, Liu, Qiaoqiao, Lin, Faquan, Zhang, Zhikun, Zhong, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666393/ https://www.ncbi.nlm.nih.gov/pubmed/37993941 http://dx.doi.org/10.1186/s12967-023-04709-z

Ejemplares similares

Study of Oncolytic Virus Preservation and Formulation
por: Pan, Lina, et al.
Publicado: (2023)

Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
por: Tang, Chao, et al.
Publicado: (2022)

Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
por: Davola, Maria Eugenia, et al.
Publicado: (2019)

Oncolytic viruses as therapeutic cancer vaccines
por: Bartlett, David L, et al.
Publicado: (2013)

Therapeutic Efficacy of Oncolytic Viruses in Fighting Cancer: Recent Advances and Perspective
por: Garmaroudi, Ghazal Asadi, et al.
Publicado: (2022)

Oncolytic Viruses: Therapeutics With an Identity Crisis
por: Breitbach, Caroline J., et al.
Publicado: (2016)

Oncolytic viruses on the cusp of success?: proceedings of the 9th International Conference on Oncolytic Virus Therapeutics
por: Peters, Cole, et al.
Publicado: (2016)

CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma
por: Lei, Wen, et al.
Publicado: (2022)

Ultrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of art
por: Nande, Rounak, et al.
Publicado: (2015)

Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus
por: Dryja, Parker, et al.
Publicado: (2023)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2017)

NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses—Therapeutic Perspectives
por: Struzik, Justyna, et al.
Publicado: (2018)

Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
por: Varela-Guruceaga, Maider, et al.
Publicado: (2018)

Therapeutic Applications for Oncolytic Self-Replicating RNA Viruses
por: Lundstrom, Kenneth
Publicado: (2022)

Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy
por: Liu, Weilin, et al.
Publicado: (2022)

Oncolytic viruses & their specific targeting to tumour cells
por: Singh, Prafull K., et al.
Publicado: (2012)

Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma
por: Phelps, Michael P., et al.
Publicado: (2018)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
por: Everts, Anne, et al.
Publicado: (2020)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression
por: Ansel, Ashley, et al.
Publicado: (2017)

Beclin1-armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R-CHOP against lymphoma in vitro and in vivo
por: Xie, Shufang, et al.
Publicado: (2021)

Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
por: Ricca, Jacob M., et al.
Publicado: (2018)

The Multifaceted Role of Macrophages in Oncolytic Virotherapy
por: Hofman, Laura, et al.
Publicado: (2021)

CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma
por: Hanauer, Julia D.S., et al.
Publicado: (2018)

Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
por: Spiesschaert, Bart, et al.
Publicado: (2021)

Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses
por: Jafari, Mahdie, et al.
Publicado: (2022)

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
por: Deng, Lili, et al.
Publicado: (2017)

In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2
por: Liu, Weilin, et al.
Publicado: (2020)

Targeting hematologic malignancies with oncolytic vaccinia virus constructs
por: Chen, Nanhai, et al.
Publicado: (2013)

Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses
por: Semenova, A. V., et al.
Publicado: (2022)

Tumour-specific triple-regulated oncolytic herpes virus to target glioma
por: Delwar, Zahid M., et al.
Publicado: (2016)

Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)

Oncolytic viruses in melanoma
por: Robinson, Camille, et al.
Publicado: (2022)

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
por: Lundstrom, Kenneth
Publicado: (2018)

IMMU-09. MODULATING THE MYELOID POPULATION IN DIPG MODELS WITH ONCOLYTIC VIRUS AND COMPLEMENT INHIBITORS SHOWS THERAPEUTIC EFFICACY
por: Puigdelloses, Montserrat, et al.
Publicado: (2021)

Development and application of oncolytic viruses as the nemesis of tumor cells
por: Zhu, Xiao, et al.
Publicado: (2023)

Oncolytic Vaccinia Virus Expressing Aphrocallistes vastus Lectin as a Cancer Therapeutic Agent
por: Wu, Tao, et al.
Publicado: (2019)

Oncolytic herpes simplex virus delivery of dual CAR targets of CD19 and BCMA as well as immunomodulators to enhance therapeutic efficacy in solid tumors combined with CAR T cell therapy
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Oncolytic Viruses as Platform for Multimodal Cancer Therapeutics: A Promising Land
por: Guo, Z. Sheng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_amsbi3g7i34si0bpniudf2orl8